| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.9 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |